Phenotype analysis of normal (MBN) and DMD-affected (MBDMD) parent cells prior to and after ex vivo fusion, demonstrated continued expression of CD56, CD90, and CD34 markers indicating maintenance of myogenic lineage by both DEC lines after fusion (Fig. 2). The gene discussed is NCAM1; the disease is Duchenne muscular dystrophy.